共 49 条
[1]
Robinson BW(2005)Malignant mesothelioma Lancet 366 397-408
[2]
Musk AW(2010)OESMO guidelines working group. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. Ann Oncol 21 v126-v128
[3]
Lake RA(2006)The experts’ conference of the Société de Pneumologie de Langue Française (SPLF) on malignant pleural mesothelioma (MPM): useful and necessary recommendations Rev Mal Respir 23 11S5-11S6S
[4]
Stahel RA(2010)European Respiratory Society/European Society of Thoracic Surgeons Task Force. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma Eur Respir J 35 479-495
[5]
Weder W(2007)BTS statement on malignant mesothelioma in the UK, 2007 Thorax 62 ii1-ii19
[6]
Lievens Y(2012)Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma J Thorac Oncol 7 595-598
[7]
Felip E(1997)The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma Chest 111 106-109
[8]
Scherpereel A(2010)The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma Diagn Cytopathol 38 874-879
[9]
Scherpereel A(2004)Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma Lung Cancer 45 S45-S48
[10]
Astoul P(2005)Prognostic factors for mesothelioma Hematol Oncol Clin North Am 19 1041-1052